RIVAROXABAN Mepha vascular cpr pell 2.5 mg 100 pce

7680684400032 CH-68440 B01AF01 06.03.0.

Reimbursement limitations:

RIVA.MEP.vas

En association avec de l’acide acétylsalicylique (AAS), pour la prévention secondaire (après événement) des événements …

RIVAROXABAN Mepha vascular cpr pell 2.5 mg 100 pce
RIVAROXABAN Mepha vascular cpr pell 2.5 mg 100 pce
RIVAROXABAN Mepha vascular cpr pell 2.5 mg 100 pce
1 / 3
google

Details

Product number
6844001
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
rivaroxabanum 2.5 mg, natrii laurilsulfas, lactosum monohydricum 184.7 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium max. 1.19 mg.

Articles (1)

Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/09/2024
Patient information leaflet
Français
17/09/2024
Patient information leaflet
Italien
17/09/2024
Professional SmPC
Allemand
17/09/2024
Professional SmPC
Français
17/09/2024
Professional SmPC
Italien
17/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
184.7 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 68.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2024

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68440
Drug name
Rivaroxaban-Mepha vascular 2.5 mg Filmtabletten
Galenic form
FILM
ATC Code
B01AF01
Authorization status
Z
Dispensation category
B
First authorization
06/04/2022
Authorization expiration date
05/04/2027
IT number
06.03.0.
Domain
Human medicine
Field of application
In Kombination mit Acetylsalicylsäure zur Prävention schwerwiegender atherothrombotischer Ereignisse bei Patienten mit koronarer Herzkrankheit oder manifester peripherer arterieller Gefässerkrankung und einem hohen Risiko für ischämische Ereignisse

Packaging details

Description (FR)
RIVAROXABAN Mepha vascular cpr pell 2.5 mg 100 pce
Description (DE)
RIVAROXABAN Mepha vascular Filmtabl 2.5 mg 100 Stk
Market launch
06/04/2022
Narcotic (BTM)
No

Original drug

Xarelto, Filmtabletten
GTIN: 7680587280014
CHF 17.25
View original

Other packaging sizes

RIVAROXABAN Mepha vascular cpr pell 2.5 mg 56 pce
56 TABL
GTIN: 7680684400018
View
RIVAROXABAN Mepha vascular cpr pell 2.5 mg 196 pce
196 TABL
GTIN: 7680684400025
View